Biomedical

Biomedical
Medical Devices
One Hot Stock

Soleno Therapeutics, Inc. (SLNO) – Buy Target – $4.00 or better

Buy Target – $4.00 or better Sell Target – TradersPro Sell Signal Soleno Therapeutics, Inc. focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, Diazoxide Choline Controlled Release (DCCR), a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a […]

Read More
Biomedical
One Hot Stock

Forty Seven, Inc. (FTSV) – Buy Target – $46.50 or better

Buy Target – $46.50 or better Sell Target – TradersPro Sell Signal Forty Seven, Inc., a clinical-stage immuno-oncology company, focuses on developing therapies to activate macrophages for the treatment of cancer. It is developing 5F9, a humanized IgG4 subclass monoclonal antibody against CD47 that is in Phase 1b/2 clinical trials used for the treatment of […]

Read More
Biomedical
Biopharmaceuticals
Biotech
Daily Rundown
Economic Trends
Economy
Industrial Sector
Industrials
Stock Picks
Tech Stocks
Theme Parks
US Economy

“This Airplane Is Designed By Clowns… Supervised By Monkeys” – Boeing Is Facing New Embarrassment Over Its Grounded 737 Max Jet

Plus, the U.S. just slapped new sanctions on Iran, the Labor Department’s December jobs report disappointed, and Six Flags received two downgrades from the same analyst in less than 24 hours.

Read More
Auto Industry
Biomedical
China
Daily Rundown
Health
HeathCare
Industrial Sector
Industrials
Retailers
Stock Picks
Streaming Media
Trade War

Bed Bath & Beyond’s New CEO Just Shook Up The Company’s Management Team In A Big Way

Plus, new details are emerging on the phase one trade deal between the U.S. and China, Boeing is officially halting production of the 737 Max, and Fiat Chrysler and Peugeot might be about to finalize a memorandum of understanding to merge.

Read More
Biomedical
Biotech
One Hot Stock

Fulgent Genetics, Inc. (FLGT) – Buy Target $13.97 or better

Buy Target $13.97 or better Sell Target – TradersPro Sell Signal Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and […]

Read More
Biomedical

Mersana Therapeutics, Inc. (MRSN) Is Up 95% This Month. Is This Just The Beginning?

Buy Target – $3.74 Sell Target – $5.23 Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company focusing on the development of antibody drug conjugate (ADC) for cancer patients with unmet need. The company develops Dolaflexin, a platform, which is used to generate a pipeline of proprietary ADC product candidates to address patient populations that are […]

Read More
Biomedical
Biopharmaceuticals
Biotech
China
Daily Rundown
Donald Trump
Economic Trends
Economy
Federal Reserve
Manufacturing
Stock Picks
Trade War
US Economy

“We’re In The final Throes Of A Very Important Deal”

Plus, the impeachment inquiry is moving on to the Judiciary Committee, the FAA is tightening its grip on Boeing, and Deere shares are sliding.

Read More
Airlines
Apple
Biomedical
Daily Rundown
Investment Banks
Stock Picks
Tech Stocks

Walgreens Has Been Formally Approached With A Deal To Go Private

Plus, there’s a new probe into Goldman Sachs’ credit card practices after some complaints related to its Apple Card, Alibaba is on track to deliver record sales for its biggest shopping event of the year, and Boeing is planning to resume shipments of its 737 Max plane in December.

Read More

[FREE EVENT]: TRADERSPRO PRESENTS - Retire In 18 Months with $2.4 Million

Starting Soon - Join Us Now
X